Results 1 to 10 of about 11,686 (159)

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis [PDF]

open access: yesOncoImmunology, 2023
Formyl peptide receptor-1 (FPR1) is a pattern recognition receptor that is mostly expressed by myeloid cells. In patients with colorectal cancer (CRC), a loss-of-function polymorphism (rs867228) in the gene coding for FPR1 has been associated with ...
Julie Le Naour   +17 more
doaj   +7 more sources

The Role of Formyl Peptide Receptor 1 in Uterine Contraction During Parturition [PDF]

open access: yesFrontiers in Pharmacology, 2021
Parturition involves the transformation of the quiescent myometrium into a highly excitable and contractile state, a process that is driven by changes in myometrial gene expression.
Chaolu Chen   +5 more
doaj   +5 more sources

Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1 [PDF]

open access: yesScientific Reports, 2017
Formyl peptide receptor 1 (FPR1) mediates bacterial and mitochondrial N-formyl peptides-induced neutrophil activation. Therefore, FPR1 is an important therapeutic target for drugs to treat septic or sterile inflammatory diseases.
Fu-Chao Liu   +7 more
doaj   +5 more sources

Inhibition of formyl peptide receptor-1-mediated cell death as a therapy for lethal cutaneous drug reactions in preclinical models [PDF]

open access: yesNature Communications
Stevens-Johnson syndrome and toxic epidermal necrolysis are life-threatening mucocutaneous adverse drug reactions characterized by disseminated skin and mucosal detachment.
Haruna Kimura   +8 more
doaj   +2 more sources

RETRACTED: Fusco et al. Formyl Peptide Receptor 1 Signaling in Acute Inflammation and Neural Differentiation Induced by Traumatic Brain Injury. Biology 2020, 9, 238 [PDF]

open access: yesBiology
The journal retracts the article, “Formyl Peptide Receptor 1 Signaling in Acute Inflammation and Neural Differentiation Induced by Traumatic Brain Injury” [...]
Roberta Fusco   +12 more
doaj   +2 more sources

Knockout of Formyl Peptide Receptor-1 Attenuates Cigarette Smoke–Induced Airway Inflammation in Mice [PDF]

open access: yesFrontiers in Pharmacology, 2021
Objective: The formyl peptide receptor-1 (FPR-1) has been reported to be implicated in the regulation of inflammatory disorders, while its role in cigarette smoke (CS)–induced airway inflammation has not been fully explained.
Lijuan Gao   +9 more
doaj   +2 more sources

An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1) [PDF]

open access: yesOncoImmunology, 2021
Formyl peptide receptor 1 (FPR1) plays a key regulatory role in innate and adaptive immunity. Recently, we reported that the CC genotype of FPR1-E346A (rs867228, c. 1037 A > C) is an independent biomarker for patients with locally advanced rectal cancer (
Shu-Fen Chiang   +5 more
doaj   +2 more sources

Monoclonal Antibody 5F1 Modulates Formyl Peptide Receptor 1 Conformation for Transmembrane Signaling [PDF]

open access: yesFASEB BioAdvances
Formyl peptide receptor 1 (FPR1) is a G protein‐coupled receptor (GPCR) that mediates chemotaxis and bactericidal activities in phagocytes. The monoclonal antibody 5F1 is generated against full‐length FPR1 and used widely for detection of FPR1 expression.
Yue Wang   +3 more
doaj   +2 more sources

Tumor suppressor function of formyl peptide receptor 1 in gastrointestinal cancers: a focus on the underlying signaling [PDF]

open access: yesFrontiers in Cell and Developmental Biology
The homeostasis of a tissue such the gastrointestinal (GI) tract is of fundamental importance for human health, given its constant exposure to a wide variety of external substances.
Maria Marotta   +3 more
doaj   +2 more sources

Increased expression of formyl peptide receptor-1 by basophils from patients with mastocytosis [PDF]

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: Symptoms in patients with systemic mastocytosis (SM) are associated with an increase in mast cell burden and release of mast cell–derived mediators.
Yuzhi Yin, MD, PhD   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy